Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3. 479 prostate biopsy cases

ABSTRACT Objectives: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifiy the risk factors and preventive factors. Materials and Methods: We retrospectively reviewed the medical records of 3.479 cases of transrectal ultrasound-guided needle biopsies performed with different prophylactic antibiotherapy regimens at two different institutions between January 2011 and February 2016. The patients of Group I have received ciprofl oxacin (n=1.523, 500mg twice daily) and the patients of Group II have received ciprofl oxacin plus ornidazole (n=1.956, 500mg twice daily) and cleansing enema combination as prophylactic antibiotherapy. The incidence, clinical features and other related microbiological and clinical data, were evaluated. Results: Mean age was 62.38±7.30 (47-75), and the mean prostate volume was 43.17±15.20 (21-100) mL. Of the 3.479 patients, 39 (1.1%) developed acute prostatitis after the prostate biopsy procedure. Of the 39 cases of acute prostatitis, 28/3.042 occurred after the first biopsy and 11/437 occurred after repeat biopsy (p=0.038). In Group I, 22 of 1.523 (1.4%) patients developed acute prostatitis. In Group II, 17 of 1.959 (0.8%) patients developed acute prostatitis. There was no statistical difference between the two groups according to acute prostatitis rates (X2=2.56, P=0.11). Further, hypertension or DM were not related to the development of acute prostatitis (P=0.76, X2=0.096 and P=0.83, X2=0.046, respectively). Conclusions: Repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential yet.

The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy

ABSTRACT Introduction: We aimed to evaluate the efficacy of the duration of prophylactic antibiotic administration in patients undergoing transrectal ultrasound (TRUS) guided biopsy. Material and Methods: A total of 367 patients undergoing a prostate biopsy between September 2007 and June 2009 was reviewed retrospectively and divided into 2 groups according to prophilaxy: oral ciprofloxacin (750 mg every 12 hours) for 3 or more days in Group-1 and single day in Group-2. Demographic characteristics of patients, symptoms, PSA values, IPSS scores, prostate sizes, pathologic results and complications were compared between the groups. Results: The mean age of all patients was 63.92 years and the mean PSA was 13.61ng/ dL. The pre-biopsy mean IPSS score was 12.47 and mean prostate volume 52.53 mL. For 78.2% of patients the current biopsy was their first biopsy. Cancer detection rate was 24.2%. Fever was observed in 3 (1.2%) patients in Group-1 and 5 (4.0%) patients in Group-2. Local infections occurred in 2 (0.8%) and 1 (0.8%) patients respectively in Groups 1 and 2. Acute prostatitis was observed in only 1 (0.8%) patient in Group-2. Accepted after revision: None of the patients developed septicemia or other serious infection. There was no statistically significant difference in terms of fever, local infections (epididimitis, orchitis, etc.) and acute prostatitis. Conclusions: In a selected patient population single dose prophylaxis with ciprofloxacin can be safely administered compared to other regimens of 3 or more days. Increasing the duration of antibiotic prophylaxis does not decrease infectious complications.

A randomized and prospective study on the value of antibiotic prophylaxis administration in transurethral resection of the prostate

CONTEXTO: A profilaxia antibiótica nas ressecções transuretrais da próstata é uma prática regular e freqüente na clínica urológica. No entanto, seu efeito profilático e bactericida protetor pode ser contestado se procedimentos assépticos são utilizados na realização da cirurgia, sobretudo em pacientes com urina estéril. No caso de infecção urinária, a identificação dos germes para escolha do antibiótico adequado pode ser necessária. OBJETIVO: Verificar a eficácia da antibioticoprofilaxia em pacientes com urina estéril submetidos a ressecção transuretral de próstata. TIPO DE ESTUDO: Prospectivo num centro de referência de tratamento urológico, aberto. LOCAL: Hospital de referência terciária. PARTICIPANTES: 124 pacientes. VARIÁVEIS ESTUDADAS: 124 pacientes consecutivos foram randomicamente divididos em dois grupos para receber ou não antibioticoterapia profilática na ressecção transuretral de próstata. Cultura do meato uretral, urina, líquido irrigante e anti-séptico, além dos fragmentos de próstata ressecados foram analisados quanto a sensibilidade a antibióticos, escolhidos a critério do cirurgião, e determinada a partir de antibiograma com as cepas bacterianas identificadas nos sítios mencionados. RESULTADOS: Não se encontrou diferença estatisticamente significante na evolução clínica de ambos os grupos. Aqueles que receberam antibioticoprofilaxia apresentaram menor freqüência de cultura urinária positiva do que aqueles que não receberam profilaxia. No entanto, na observação da evolução clínica de ambos os grupos, o uso de antibiótico não mostrou qualquer benefício no que concerne à ocorrência de febre, positividade das culturas obtidas dos fragmentos de próstata ressecados ou episódios de bacteremia. 68 casos (57,1%) apresentaram cultura positiva do tecido prostático. Entretanto, não houve correlação entre a bactéria identificada a partir do tecido prostático e de outros locais, tais como meato, urina, líquido irrigante ou anti-séptico utilizado. Somente em seis casos foi encontrada a mesma bactéria no tecido prostático e na urina pós-operatória. Apenas em 15 casos (25%) do grupo antibiótico observou-se a sensibilidade esperada da bactéria identificada ao antibiótico utilizado...